Pune, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Animal Model Market Size & Growth Analysis:
According to SNS Insider, the Animal Model Market was valued at USD 2.3 billion in 2023 and is anticipated to reach USD 4.6 billion by 2032, with a growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2024 to 2032.
The growth of the animal model market is closely related to the growing need for animal-based research models to develop new drugs and therapies.
The importance of animal models will be particularly critical in diverse areas of research such as the study of human disease, vaccine development, and testing new therapeutics. A further boost to this market is provided by the huge investments by governments and research institutions worldwide into animal-based research models. For example, the U.S. National Institutes of Health (NIH) allocated approximately USD 2.5 billion for animal research in 2023 to support preclinical trials and drug development. Likewise, the Horizon Europe program by the European Commission allocates 15% more funding to research using animal models to stimulate innovative research in pharmaceutical and biotechnology development. The FDA has also emphasized the importance of using animal models in drug approval processes, ensuring that these models meet stringent regulatory standards.
Get a Sample Report of Animal Model Market@ https://www.snsinsider.com/sample-request/3789
The market's rapid growth can also be attributed to the increasing use of animal models in cancer research, neurological diseases, and infectious diseases. Such animal models are vital to elucidating the mechanisms underlying these diseases and for assessing potential therapies before they are tested in the clinic. According to the American Cancer Society, recent figures indicate that cancer is the second leading cause of death in the U.S., with 1,898,160 new cancer cases diagnosed in 2023. This has resulted in a recent shift to focus on preclinical testing in animal models of effective cancer therapies. Finally, animal models are making an important contribution to response to the new challenges posed by the increasing burden of chronic diseases and emerging and re-emerging viral infections, such as COVID-19. The development of vaccines and treatments for COVID-19 involved the rapid use of animal models, highlighting their importance in responding to global health emergencies.
Major Players Analysis Listed in this Report are:
- Charles River Laboratories
- Envigo
- Taconic Biosciences
- Harlan Laboratories
- Janvier Labs
- Shanghai Model Organisms Center
- Crown Bioscience
- The Jackson Laboratory
- BioIVT
- Inotiv
- quamma
Animal Model Market Report Scope:
| Report Attributes | Details |
| Market Size in 2023 | US$ 2.3 billion |
| Market Size by 2032 | US$ 4.6 billion |
| CAGR | CAGR of 8.2% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segment Analysis
By Animal Type
The largest market share was held by the mice segment with a revenue share of 51% in 2023. Mice are the most widely used animal models in preclinical studies because of their genetic similarities to humans, and animal models for many diseases already exist for clinical studies. Mice models are still a staple of the foundation of research scientists doing cancer research, immunology, or neurological disease investigations.
Rats followed close behind, representing a considerable portion of the rodent market, as they are widely utilized in chronic disease models and behavioural studies. Other animal species Ducks and turkeys, hamsters, guinea pigs, non-human primates, and rabbits are also often used, especially to test drug toxicity and in vaccine research.
By Application
In 2023, the cancer segment dominated the market and accounted for 41% of the overall share. Cancer research continues to be a primary application of animal models as it facilitates the understanding of tumor biology, treatment responses, and the development of targeted therapies. With the rising global incidence of cancer and the need for novel treatments, the demand for animal models in oncology research is expected to remain strong throughout the forecast period.
By End-Use
The Pharmaceutical and biotechnology companies segment held the largest revenue share 38% of the market in 2023. These companies rely heavily on animal models to evaluate the safety and efficacy of new drugs and biologics before clinical trials. The rising number of drug development initiatives and the growing investment in personalized medicine are key factors driving this market segment.
Academic and research institutions also represent a significant portion of the end-use market, particularly in basic and preclinical research. These institutions use animal models to study disease mechanisms and test potential therapeutic compounds.
Need any customization research on Animal Model Market, Enquire Now@ https://www.snsinsider.com/enquiry/3789
Animal Model Market Key Segmentation:
By Animal Type
- Mice
- Rat
- Guinea Pigs
- Rabbits
- Hamsters
- Others
By Application
- Cancer
- Immunological Disease
- Infectious Disease
- Others
By End-use
- Pharmaceutical & Biotechnology Companies
- Academic Research Institute
- Contract Research Organization
Regional Analysis
North America
North America held the largest market share in 2023, accounting for 43% of the global animal model market. The U.S. is the key contributor to this dominance, thanks to its robust healthcare and research infrastructure, coupled with substantial government funding for scientific research. The NIH’s continuous support for preclinical research, along with the high number of pharmaceutical companies operating in the region, fuels the demand for animal models. Additionally, the rising prevalence of chronic diseases and cancer has made animal models indispensable in clinical research.
The Asia-Pacific region is emerging as the fastest-growing market for animal models, with China and India being the key drivers. The rapid expansion of healthcare infrastructure, increasing investments in pharmaceutical research, and growing awareness of the importance of preclinical trials are contributing to the rise in demand for animal models. China’s State Council has recognized the need for animal-based research in advancing drug development and has made significant strides in improving research standards. Countries like Japan and South Korea are also increasing their focus on animal research to support drug discovery and personalized medicine. As the region’s economy continues to grow, the demand for advanced animal models in both private and public sector research is expected to soar.
Recent Developments
- In May 2024, Charles River Laboratories announced the launch of a new breeding program focused on producing genetically modified mice for oncology research. This development is expected to provide researchers with more accurate animal models for cancer studies.
- In April 2024, Envigo, a global provider of animal testing services, unveiled a new non-human primate breeding facility in India. The new facility will cater to the increasing demand for primates in neurological and infectious disease research.
Buy a Single-User PDF of Animal Model Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/3789
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
7. Animal Model Market Segmentation, by Animal Type
8. Animal Model Market Segmentation, by Application
9. Animal Model Market Segmentation, by End-use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Access Complete Report Details of Animal Model Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/animal-model-market-3789
Buying Options
5 Reports Pack (USD 7500)
10 Report Pack (USD 12000)
Vertical Subscription (150 Reports Pack Valid for 1 Year)
Use this link to Purchase above packs @ https://www.snsinsider.com/subscription
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
